Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) Recruiting Phase 4 Trials for Lymphoma / Coronavirus Disease 2019 (COVID‑19) Basic Science

IndicationsStatusPurposePhase
RecruitingBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT05170399Vaccine Responses in Patients With B Cell Malignancies